Quantcha now offering unlimited commission-free options trading. Quantchabot has detected a promising Synthetic Long Stock trade opportunity for INTRA-CELLULAR THERAPIES INC. (ITCI) for the 18-Feb-2022 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine. ITCI was recently trading at $56.00 and has an implied volatility of 59.23% for this period. Based on an analysis of the options available for ITCI expiring on 18-Feb-2022, there is a 34.84% likelihood that the underlying will close within the analyzed range of $56.00-$59.44 at expiration. In this scenario, the average linear return for the trade would be 13.03%. 52 week high: INTRA-CELLULAR THERAPIES INC. recently reached a new 52-week high at $56.01. ITCI had traded in the range $28.40-$55.20 over the past year. Trade approach: Reaching a new 52-week high is a bullish indicator, so this trade is designed to be profitable if ITCI maintains its current direction and does not revert back to pricing on the bearish side of $56.00 on 18-Feb-2022. If possible, the trade has been padded such that slight movement against the trade would still return a profit. Upside potential: Using this bullish strategy, the trade would be profitable if INTRA-CELLULAR THERAPIES INC. closes at or above $56.00 on 18-Feb-2022. Based on our risk-neutral analysis, there is a 50.01% likelihood of this return. Downside risk: As with any options trade, there is a substantial downside risk where you may lose most or all of your investment. To analyze this trade in depth, please visit the Quantcha Options Search Engine.